STOK vs. LLY
Compare and contrast key facts about Stoke Therapeutics, Inc. (STOK) and Eli Lilly and Company (LLY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: STOK or LLY.
Correlation
The correlation between STOK and LLY is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
STOK vs. LLY - Performance Comparison
Key characteristics
STOK:
0.53
LLY:
0.53
STOK:
1.77
LLY:
0.94
STOK:
1.20
LLY:
1.12
STOK:
0.59
LLY:
0.67
STOK:
2.17
LLY:
1.55
STOK:
25.23%
LLY:
10.54%
STOK:
102.90%
LLY:
30.86%
STOK:
-95.17%
LLY:
-68.27%
STOK:
-88.07%
LLY:
-8.69%
Fundamentals
STOK:
$441.22M
LLY:
$784.71B
STOK:
-$2.08
LLY:
$11.70
STOK:
$13.94M
LLY:
$45.04B
STOK:
$10.61M
LLY:
$36.76B
STOK:
-$86.61M
LLY:
$15.63B
Returns By Period
In the year-to-date period, STOK achieves a -24.48% return, which is significantly lower than LLY's 13.37% return.
STOK
-24.48%
-16.87%
-40.46%
56.58%
-21.26%
N/A
LLY
13.37%
16.08%
-7.99%
14.26%
45.71%
31.03%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
STOK vs. LLY — Risk-Adjusted Performance Rank
STOK
LLY
STOK vs. LLY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Stoke Therapeutics, Inc. (STOK) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
STOK vs. LLY - Dividend Comparison
STOK has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.62%.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOK Stoke Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LLY Eli Lilly and Company | 0.62% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.95% | 2.46% | 2.77% | 2.37% | 2.84% |
Drawdowns
STOK vs. LLY - Drawdown Comparison
The maximum STOK drawdown since its inception was -95.17%, which is greater than LLY's maximum drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for STOK and LLY. For additional features, visit the drawdowns tool.
Volatility
STOK vs. LLY - Volatility Comparison
Stoke Therapeutics, Inc. (STOK) has a higher volatility of 26.20% compared to Eli Lilly and Company (LLY) at 7.16%. This indicates that STOK's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
STOK vs. LLY - Financials Comparison
This section allows you to compare key financial metrics between Stoke Therapeutics, Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities